NRX Pharmaceuticals Stock Forecast - Triple Exponential Smoothing

NRXP Stock  USD 1.19  0.02  1.65%   
The Triple Exponential Smoothing forecasted value of NRX Pharmaceuticals on the next trading day is expected to be 1.17 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.33. NRX Stock Forecast is based on your current time horizon. Although NRX Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of NRX Pharmaceuticals' systematic risk associated with finding meaningful patterns of NRX Pharmaceuticals fundamentals over time.
  
As of 12/11/2024, Inventory Turnover is likely to grow to -0.62. In addition to that, Payables Turnover is likely to drop to 0. As of 12/11/2024, Common Stock Shares Outstanding is likely to drop to about 7.2 M. In addition to that, Net Loss is likely to drop to about (37.6 M).
Triple exponential smoothing for NRX Pharmaceuticals - also known as the Winters method - is a refinement of the popular double exponential smoothing model with the addition of periodicity (seasonality) component. Simple exponential smoothing technique works best with data where there are no trend or seasonality components to the data. When NRX Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any trend in NRX Pharmaceuticals price movement. However, neither of these exponential smoothing models address any seasonality of NRX Pharmaceuticals.

NRX Pharmaceuticals Triple Exponential Smoothing Price Forecast For the 12th of December 2024

Given 90 days horizon, the Triple Exponential Smoothing forecasted value of NRX Pharmaceuticals on the next trading day is expected to be 1.17 with a mean absolute deviation of 0.04, mean absolute percentage error of 0, and the sum of the absolute errors of 2.33.
Please note that although there have been many attempts to predict NRX Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that NRX Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

NRX Pharmaceuticals Stock Forecast Pattern

Backtest NRX PharmaceuticalsNRX Pharmaceuticals Price PredictionBuy or Sell Advice 

NRX Pharmaceuticals Forecasted Value

In the context of forecasting NRX Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. NRX Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 4.89, respectively. We have considered NRX Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.19
1.17
Expected Value
4.89
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Triple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of NRX Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent NRX Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0127
MADMean absolute deviation0.0395
MAPEMean absolute percentage error0.0293
SAESum of the absolute errors2.33
As with simple exponential smoothing, in triple exponential smoothing models past NRX Pharmaceuticals observations are given exponentially smaller weights as the observations get older. In other words, recent observations are given relatively more weight in forecasting than the older NRX Pharmaceuticals observations.

Predictive Modules for NRX Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NRX Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NRX Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.184.90
Details
Intrinsic
Valuation
LowRealHigh
0.081.645.36
Details
3 Analysts
Consensus
LowTargetHigh
2.803.083.42
Details

Other Forecasting Options for NRX Pharmaceuticals

For every potential investor in NRX, whether a beginner or expert, NRX Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. NRX Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in NRX. Basic forecasting techniques help filter out the noise by identifying NRX Pharmaceuticals' price trends.

NRX Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NRX Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of NRX Pharmaceuticals could also be used in its relative valuation, which is a method of valuing NRX Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

NRX Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of NRX Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of NRX Pharmaceuticals' current price.

NRX Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how NRX Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NRX Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying NRX Pharmaceuticals stock market strength indicators, traders can identify NRX Pharmaceuticals entry and exit signals to maximize returns.

NRX Pharmaceuticals Risk Indicators

The analysis of NRX Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in NRX Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting nrx stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with NRX Pharmaceuticals

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NRX Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NRX Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Moving together with NRX Stock

  0.67VALN Valneva SE ADRPairCorr
  0.67ERNA Eterna TherapeuticsPairCorr

Moving against NRX Stock

  0.77BMY Bristol Myers SquibbPairCorr
  0.76GILD Gilead SciencesPairCorr
  0.64ESPR Esperion TherapeuticsPairCorr
  0.45DNA Ginkgo Bioworks HoldingsPairCorr
  0.44FLGC Flora Growth CorpPairCorr
The ability to find closely correlated positions to NRX Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NRX Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NRX Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NRX Pharmaceuticals to buy it.
The correlation of NRX Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NRX Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NRX Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NRX Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.